1. Home
  2. IPSC vs FSI Comparison

IPSC vs FSI Comparison

Compare IPSC & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • FSI
  • Stock Information
  • Founded
  • IPSC 2019
  • FSI 1991
  • Country
  • IPSC United States
  • FSI Canada
  • Employees
  • IPSC N/A
  • FSI N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • FSI Recreational Games/Products/Toys
  • Sector
  • IPSC Health Care
  • FSI Consumer Discretionary
  • Exchange
  • IPSC Nasdaq
  • FSI Nasdaq
  • Market Cap
  • IPSC 47.4M
  • FSI 55.6M
  • IPO Year
  • IPSC 2021
  • FSI 1999
  • Fundamental
  • Price
  • IPSC $0.50
  • FSI $5.53
  • Analyst Decision
  • IPSC Strong Buy
  • FSI
  • Analyst Count
  • IPSC 5
  • FSI 0
  • Target Price
  • IPSC $3.33
  • FSI N/A
  • AVG Volume (30 Days)
  • IPSC 940.0K
  • FSI 27.9K
  • Earning Date
  • IPSC 08-22-2025
  • FSI 08-22-2025
  • Dividend Yield
  • IPSC N/A
  • FSI 1.76%
  • EPS Growth
  • IPSC N/A
  • FSI N/A
  • EPS
  • IPSC N/A
  • FSI 0.18
  • Revenue
  • IPSC $114,898,000.00
  • FSI $36,483,680.00
  • Revenue This Year
  • IPSC $1,590.09
  • FSI $14.71
  • Revenue Next Year
  • IPSC N/A
  • FSI $51.14
  • P/E Ratio
  • IPSC N/A
  • FSI $30.45
  • Revenue Growth
  • IPSC 8286.72
  • FSI N/A
  • 52 Week Low
  • IPSC $0.34
  • FSI $1.65
  • 52 Week High
  • IPSC $2.05
  • FSI $7.24
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 41.82
  • FSI 53.86
  • Support Level
  • IPSC $0.52
  • FSI $5.38
  • Resistance Level
  • IPSC $0.57
  • FSI $5.49
  • Average True Range (ATR)
  • IPSC 0.05
  • FSI 0.31
  • MACD
  • IPSC -0.01
  • FSI -0.02
  • Stochastic Oscillator
  • IPSC 7.37
  • FSI 72.45

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: